TY - JOUR
T1 - Evaluation of a Randomized Clinical Trial Comparing the Effectiveness of a Culturally Targeted and Nontargeted Smoking Cessation Intervention for Lesbian, Gay, Bisexual, and Transgender Smokers
AU - Matthews, Alicia K.
AU - Steffen, Alana D.
AU - Kuhns, Lisa M.
AU - Ruiz, Raymond A.
AU - Ross, Nat A.
AU - Burke, Larisa A.
AU - Li, Chien Ching
AU - King, Andrea C.
N1 - Funding Information:
This research was supported by the National Institute on Drug Abuse (R01 DA023935-01A2, AKM), and The University of Illinois at Chicago (UIC) Center for Clinical and Translational Science (CCTS) is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1TR002003 (Tobacman and Mermelstein, 2016), the NCI P20 CA202908-01 (Winn), and National Cancer Institute grant #P30-CA14599 to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the office views of the National Institutes of Health.
Publisher Copyright:
© 2018 The Author(s).
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Purpose: To examine the benefits of a culturally targeted compared with a nontargeted smoking cessation intervention on smoking cessation outcomes among lesbian, gay, bisexual, and transgender (LGBT) smokers. Methods: A prospective randomized design was used to evaluate the added benefits of an LGBT culturally targeted Courage to Quit (CTQ-CT) smoking cessation treatment (N = 172) compared with the standard intervention (CTQ; N = 173). The smoking cessation program consisted of six treatment sessions combined with 8 weeks of nicotine replacement therapy. The primary smoking cessation outcome was 7-day point prevalence quit rates. Secondary outcomes examined included changes in nicotine dependence, nicotine withdrawal, cigarettes per day, smoking urges, self-efficacy, and readiness to quit. Results: Overall quit rates were 31.9% at 1 month, 21.1% at 3 months, 25.8% at 6 months, and 22.3% at 12 months. Quit rates did not differ between treatment groups [1 month OR = 0.81 (0.32, 2.09), 3 months OR = 0.65 (0.23, 1.78), 6 months OR = 0.45 (0.17, 1.21), 12 months OR = 0.70 (0.26, 1.91)]. Compared with baseline levels, all secondary smoking cessation outcomes measured were improved at 1 month and were maintained at 12-month follow-up. Compared with the CTQ, the CTQ-CT intervention was more highly rated on program effectiveness (d = 0.2, p =. 011), intervention techniques (d = 0.2, p =. 014), the treatment manual (d = 0.3, p <. 001), and being targeted to the needs of LGBT smokers (d = 0.5, p <. 0001). Conclusions: LGBT smokers receiving the CTQ intervention achieved smoking cessation outcomes in the range reported for other demographic groups. Cultural targeting improved the acceptability of the intervention but did not confer any additional benefit for smoking cessation outcomes. Implications: Study results have implications for understanding the benefits of culturally targeted compared with nontargeted smoking cessation interventions for improving smoking cessation outcomes among LGBT smokers. Shorter and longer term 7-day point prevalence quit rates associated with the targeted and nontargeted interventions were modest but comparable with other group-based interventions delivered in a community setting. Although cultural targeting improved the overall acceptability of the intervention, no added benefits were observed for the culturally targeted intervention on either the primary or secondary outcomes.
AB - Purpose: To examine the benefits of a culturally targeted compared with a nontargeted smoking cessation intervention on smoking cessation outcomes among lesbian, gay, bisexual, and transgender (LGBT) smokers. Methods: A prospective randomized design was used to evaluate the added benefits of an LGBT culturally targeted Courage to Quit (CTQ-CT) smoking cessation treatment (N = 172) compared with the standard intervention (CTQ; N = 173). The smoking cessation program consisted of six treatment sessions combined with 8 weeks of nicotine replacement therapy. The primary smoking cessation outcome was 7-day point prevalence quit rates. Secondary outcomes examined included changes in nicotine dependence, nicotine withdrawal, cigarettes per day, smoking urges, self-efficacy, and readiness to quit. Results: Overall quit rates were 31.9% at 1 month, 21.1% at 3 months, 25.8% at 6 months, and 22.3% at 12 months. Quit rates did not differ between treatment groups [1 month OR = 0.81 (0.32, 2.09), 3 months OR = 0.65 (0.23, 1.78), 6 months OR = 0.45 (0.17, 1.21), 12 months OR = 0.70 (0.26, 1.91)]. Compared with baseline levels, all secondary smoking cessation outcomes measured were improved at 1 month and were maintained at 12-month follow-up. Compared with the CTQ, the CTQ-CT intervention was more highly rated on program effectiveness (d = 0.2, p =. 011), intervention techniques (d = 0.2, p =. 014), the treatment manual (d = 0.3, p <. 001), and being targeted to the needs of LGBT smokers (d = 0.5, p <. 0001). Conclusions: LGBT smokers receiving the CTQ intervention achieved smoking cessation outcomes in the range reported for other demographic groups. Cultural targeting improved the acceptability of the intervention but did not confer any additional benefit for smoking cessation outcomes. Implications: Study results have implications for understanding the benefits of culturally targeted compared with nontargeted smoking cessation interventions for improving smoking cessation outcomes among LGBT smokers. Shorter and longer term 7-day point prevalence quit rates associated with the targeted and nontargeted interventions were modest but comparable with other group-based interventions delivered in a community setting. Although cultural targeting improved the overall acceptability of the intervention, no added benefits were observed for the culturally targeted intervention on either the primary or secondary outcomes.
UR - http://www.scopus.com/inward/record.url?scp=85074262895&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074262895&partnerID=8YFLogxK
U2 - 10.1093/ntr/nty184
DO - 10.1093/ntr/nty184
M3 - Article
C2 - 30169797
AN - SCOPUS:85074262895
SN - 1462-2203
VL - 21
SP - 1506
EP - 1516
JO - Nicotine and Tobacco Research
JF - Nicotine and Tobacco Research
IS - 11
ER -